| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ACCORD COPD II: A Randomized Clinical Trial to Evaluate the 12-Week Efficacy and Safety of Twice-Daily Aclidinium Bromide in Chronic Obstructive Pulmonary Disease Patients
|
Rennard, Stephen I.
|
|
2013
|
|
12 |
p. 893-904
|
article
|
| 2 |
Acetazolamide as Add-on Diuretic Therapy in Exacerbations of Chronic Heart Failure: a Pilot Study
|
Imiela, Tomasz
|
|
|
|
12 |
p. 1175-1181
|
article
|
| 3 |
Acetazolamide as Add-on Diuretic Therapy in Exacerbations of Chronic Heart Failure: a Pilot Study
|
Imiela, Tomasz
|
|
2017
|
|
12 |
p. 1175-1181
|
article
|
| 4 |
Achieving Sustained Virological Response in Hepatitis C Reduces the Long-Term Risk of Hepatocellular Carcinoma: An Updated Meta-Analysis Employing Relative and Absolute Outcome Measures
|
Messori, Andrea
|
|
2015
|
|
12 |
p. 843-850
|
article
|
| 5 |
Acknowledgement
|
|
|
2010
|
|
12 |
p. 805-810
|
article
|
| 6 |
Acknowledgement Letter CDI 32 (12)
|
|
|
2012
|
|
12 |
p. 779-781
|
article
|
| 7 |
Acknowledgements
|
|
|
2014
|
|
12 |
p. 829-831
|
article
|
| 8 |
Acknowledgement to Referees
|
|
|
|
|
12 |
p. 1103-1106
|
article
|
| 9 |
Acknowledgement to Referees
|
|
|
|
|
12 |
p. 1021-1024
|
article
|
| 10 |
Acknowledgement to Referees
|
|
|
2017
|
|
12 |
p. 1103-1106
|
article
|
| 11 |
Acknowledgement to Referees
|
|
|
2015
|
|
12 |
p. 773-775
|
article
|
| 12 |
Acknowledgement to Referees
|
|
|
2016
|
|
12 |
p. 981-984
|
article
|
| 13 |
Acknowledgement to Referees
|
|
|
2013
|
|
12 |
p. 863-865
|
article
|
| 14 |
Acknowledgement to Referees
|
|
|
2018
|
|
12 |
p. 1085-1088
|
article
|
| 15 |
Acknowledgement to Referees
|
|
|
2019
|
|
12 |
p. 1149-1152
|
article
|
| 16 |
Acknowledgement to Referees
|
|
|
|
|
12 |
p. 1021-1025
|
article
|
| 17 |
Acknowledgement to Referees
|
|
|
|
|
12 |
p. 1093-1096
|
article
|
| 18 |
Acknowledgement to Referees
|
|
|
|
|
12 |
p. 889-892
|
article
|
| 19 |
Add-On Treatment with Pregabalin for Patients with Uncontrolled Neuropathic Pain Who Have Been Referred to Pain Clinics
|
Calle, José-Luis de la
|
|
2014
|
|
12 |
p. 833-844
|
article
|
| 20 |
Adherence to Desvenlafaxine Versus Usual Care and Its Impact on Health Outcomes: A Comparative Real-world Clinical Study
|
Cardoner, Narcís
|
|
|
|
12 |
p. 1055-1066
|
article
|
| 21 |
An Open-Label Drug–Drug Interaction Study of the Steady-State Pharmacokinetics of Topiramate and Glyburide in Patients with Type 2 Diabetes Mellitus
|
Manitpisitkul, Prasarn
|
|
2013
|
|
12 |
p. 929-938
|
article
|
| 22 |
An Open-Label Study of the Pharmacokinetics and Tolerability of Once-a-Day Fentanyl Citrate Patch in Japanese Pediatric and Adolescent Patients with Cancer Pain
|
Hiyama, Eiso
|
|
|
|
12 |
p. 1087-1098
|
article
|
| 23 |
Antiplatelet Efficacy of Fixed-Dose Aspirin–Clopidogrel Combination in Patients with Stable Coronary Artery Disease Treated with Drug-Eluting Stent Implantation
|
Lim, Sungmin
|
|
2015
|
|
12 |
p. 833-842
|
article
|
| 24 |
A Phase I Dose-Escalation and Bioequivalence Study of a Trastuzumab Biosimilar in Healthy Male Volunteers
|
Wisman, Liselijn A. B.
|
|
2014
|
|
12 |
p. 887-894
|
article
|
| 25 |
A Randomized, Double-blind, Active-Controlled, Multi-center Study of Ilaprazole in the Treatment of Reflux Esophagitis
|
Xue, Yan
|
|
2016
|
|
12 |
p. 985-992
|
article
|
| 26 |
Aripiprazole in Acute Mania and Long-Term Treatment of Bipolar Disorder
|
Fazio, Pasquale De
|
|
2010
|
|
12 |
p. 827-841
|
article
|
| 27 |
A Systematic Review of Economic Evaluations Assessing the Cost-Effectiveness of Licensed Drugs Used for Previously Treated Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) Negative Advanced/Metastatic Non-Small Cell Lung Cancer
|
Gallacher, Daniel
|
|
2019
|
|
12 |
p. 1153-1174
|
article
|
| 28 |
Author Correction to: In Vitro Drug Release After Crushing: Evaluation of Xtampza® ER and Other ER Opioid Formulations
|
Mayock, Stephen P.
|
|
|
|
12 |
p. 1203
|
article
|
| 29 |
Author Correction to: In Vitro Drug Release After Crushing: Evaluation of Xtampza® ER and Other ER Opioid Formulations
|
Mayock, Stephen P.
|
|
2017
|
|
12 |
p. 1203
|
article
|
| 30 |
Bemiparin Versus Unfractionated Heparin as Bridging Therapy in the Perioperative Management of Patients on Vitamin K Antagonists: The BERTA Study
|
Santamaría, Amparo
|
|
2013
|
|
12 |
p. 921-928
|
article
|
| 31 |
Bioequivalence and Pharmacokinetics of Bisoprolol–Amlodipine 5 mg/5 mg Combination Tablet versus Bisoprolol 5 mg Tablet and Amlodipine 5 mg Tablet: An Open-Label, Randomized, Two-Sequence Crossover Study in Healthy Chinese Subjects
|
Hu, Chaoying
|
|
2018
|
|
12 |
p. 1145-1154
|
article
|
| 32 |
Bioequivalence of Sitagliptin/Metformin Fixed-Dose Combination Tablets and Concomitant Administration of Sitagliptin and Metformin in Healthy Adult Subjects
|
Migoya, Elizabeth M.
|
|
2010
|
|
12 |
p. 855-866
|
article
|
| 33 |
Budget Impact Analysis of Idecabtagene Vicleucel for the Treatment of Adult Patients with Relapsed or Refractory Multiple Myeloma in the US
|
Ghanem, Buthainah
|
|
|
|
12 |
p. 1085-1092
|
article
|
| 34 |
Calcium Channel Blockers in Secondary Cardiovascular Prevention and Risk of Acute Events: Real-World Evidence from Nested Case–Control Studies on Italian Hypertensive Elderly
|
Bettiol, Alessandra
|
|
|
|
12 |
p. 1165-1174
|
article
|
| 35 |
Calcium Channel Blockers in Secondary Cardiovascular Prevention and Risk of Acute Events: Real-World Evidence from Nested Case–Control Studies on Italian Hypertensive Elderly
|
Bettiol, Alessandra
|
|
2017
|
|
12 |
p. 1165-1174
|
article
|
| 36 |
Cardiovascular Toxicities with Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer Patients: A Meta-Analysis of 77 Randomized Controlled Trials
|
Li, Jing
|
|
2018
|
|
12 |
p. 1109-1123
|
article
|
| 37 |
Characteristics and Clinical Implications of the Pharmacokinetic Profile of Ibuprofen in Patients with Knee Osteoarthritis
|
Gallelli, L.
|
|
2012
|
|
12 |
p. 827-833
|
article
|
| 38 |
Clinical and Laboratory Factors Related to Seizure and Serotonin Toxicity in Tramadol Intoxication: An Egyptian Study
|
Ali, Ahmed Amin
|
|
|
|
12 |
p. 963-971
|
article
|
| 39 |
Comment on: Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database
|
Picaut, Philippe
|
|
2018
|
|
12 |
p. 1197-1198
|
article
|
| 40 |
Comparative Pharmacokinetics/Pharmacodynamics of Clopidogrel Besylate and Clopidogrel Bisulfate in Healthy Korean Subjects
|
Kim, Bo-Hyung
|
|
|
|
12 |
p. 817-826
|
article
|
| 41 |
Comparative Pharmacokinetics/Pharmacodynamics of Clopidogrel Besylate and Clopidogrel Bisulfate in Healthy Korean Subjects
|
Kim, Bo-Hyung
|
|
2012
|
|
12 |
p. 817-826
|
article
|
| 42 |
Concomitant Administration of Direct Oral Anticoagulants in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors
|
Serrao, Alessandra
|
|
|
|
12 |
p. 1177-1181
|
article
|
| 43 |
Correction: Pharmacokinetics and Safety of Erenumab after a Single Subcutaneous Injection Dose in Healthy Chinese Subjects
|
Shen, Qi
|
|
|
|
12 |
p. 973-974
|
article
|
| 44 |
Cost Effectiveness of Apixaban and Enoxaparin for the Prevention of Venous Thromboembolism After Total Knee Replacement in China
|
Yan, Xiaoyu
|
|
2016
|
|
12 |
p. 1001-1010
|
article
|
| 45 |
Cost-Effectiveness of Lenvatinib Compared with Sorafenib for the First-Line Treatment of Advanced Hepatocellular Carcinoma in Australia
|
Saiyed, Masnoon
|
|
|
|
12 |
p. 1167-1176
|
article
|
| 46 |
Cost-Utility Analysis Comparing Direct Oral Anticoagulant and Low Molecular Weight Heparin Therapies for Secondary Prevention of Cancer-Associated Thrombosis
|
Shin, Young Eun
|
|
|
|
12 |
p. 1075-1083
|
article
|
| 47 |
Cost-utility of Sunitinib Versus Pazopanib in Metastatic Renal Cell Carcinoma in Canada using Real-world Evidence
|
Nazha, Sara
|
|
2018
|
|
12 |
p. 1155-1165
|
article
|
| 48 |
COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study
|
Ferrara, Francesco
|
|
|
|
12 |
p. 1065-1074
|
article
|
| 49 |
Data Mining for Adverse Events of Tumor Necrosis Factor-Alpha Inhibitors in Pediatric Patients: Tree-Based Scan Statistic Analyses of Danish Nationwide Health Data
|
Wintzell, Viktor
|
|
|
|
12 |
p. 1147-1154
|
article
|
| 50 |
Defibrotide: A Review of Its Use in Severe Hepatic Veno-Occlusive Disease Following Haematopoietic Stem Cell Transplantation
|
Keating, Gillian M.
|
|
2014
|
|
12 |
p. 895-904
|
article
|
| 51 |
Depicting Risperidone Safety Profiles in Clinical Trials Across Different Diagnoses Using a Dopamine D2-Based Pharmacological Class Effect Query Defined by FAERS
|
Hopkins, Seth C.
|
|
|
|
12 |
p. 1113-1121
|
article
|
| 52 |
Depicting Safety Profile of TAAR1 Agonist Ulotaront Relative to Reactions Anticipated for a Dopamine D2-Based Pharmacological Class in FAERS
|
Hopkins, Seth C.
|
|
|
|
12 |
p. 1067-1073
|
article
|
| 53 |
Differential Antiviral Effects of Pegylated Interferon-α2a and Pegylated Interferon-α2b in Chronic Hepatitis C
|
Durante-Mangoni, Emanuele
|
|
2014
|
|
12 |
p. 871-878
|
article
|
| 54 |
Economic Evaluations of Tyrosine Kinase Inhibitors for Patients with Chronic Myeloid Leukemia in Middle- and High-Income Countries: A Systematic Review
|
Fu, Jie
|
|
2018
|
|
12 |
p. 1167-1178
|
article
|
| 55 |
Effect of Febuxostat, a Xanthine Oxidase Inhibitor, on Cardiovascular Risk in Hyperuricemic Patients with Hypertension: A Prospective, Open-label, Pilot Study
|
Tani, Shigemasa
|
|
2015
|
|
12 |
p. 823-831
|
article
|
| 56 |
Effect of Food on the Pharmacokinetics of Single- and Multiple-Dose Hydrocodone Extended Release in Healthy Subjects
|
Bond, Mary
|
|
|
|
12 |
p. 1153-1163
|
article
|
| 57 |
Effect of Food on the Pharmacokinetics of Single- and Multiple-Dose Hydrocodone Extended Release in Healthy Subjects
|
Bond, Mary
|
|
2017
|
|
12 |
p. 1153-1163
|
article
|
| 58 |
Effect of Macitentan on the Pharmacokinetics of the Breast Cancer Resistance Protein Substrates, Rosuvastatin and Riociguat, in Healthy Male Subjects
|
Csonka, Dénes
|
|
2019
|
|
12 |
p. 1223-1232
|
article
|
| 59 |
Effects of Phenobarbital and Levetiracetam on PR and QTc Intervals in Patients with Post-Stroke Seizure
|
Siniscalchi, Antonio
|
|
2014
|
|
12 |
p. 879-886
|
article
|
| 60 |
Effects of Rifampicin (Rifampin) on the Pharmacokinetics and Safety of Ambrisentan in Healthy Subjects
|
Harrison, Brooke
|
|
2010
|
|
12 |
p. 875-885
|
article
|
| 61 |
Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention
|
Jiao, Yungen
|
|
2015
|
|
12 |
p. 777-784
|
article
|
| 62 |
Efficacy and Safety of Saroglitazar in Patients with Cardiometabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
|
Durga, Devarapalli Ranjani
|
|
|
|
12 |
p. 1049-1064
|
article
|
| 63 |
Efficacy and Safety of Switching from Sitagliptin to Ipragliflozin in Obese Japanese Patients with Type 2 Diabetes Mellitus: A Single-Arm Multicenter Interventional Study
|
Watanabe, Kentaro
|
|
|
|
12 |
p. 927-937
|
article
|
| 64 |
Efficacy of Interferon-β in Moderate-to-Severe Hospitalised Cases of COVID-19: A Systematic Review and Meta-analysis
|
Kumar, Subodh
|
|
|
|
12 |
p. 1037-1046
|
article
|
| 65 |
Efficacy of the Topical Calcineurin Inhibitors Tacrolimus and Pimecrolimus in the Treatment of Vitiligo in Infants Under 2 Years of Age: A Randomized, Open-Label Pilot Study
|
Hu, Wenting
|
|
2019
|
|
12 |
p. 1233-1238
|
article
|
| 66 |
Egyptian Atherosclerosis and Vascular Biology Association Consensus on the Use of Sodium Glucose Cotransporter-2 Inhibitors in Heart Failure with Reduced Ejection Fraction
|
Elserafy, Ahmed S.
|
|
|
|
12 |
p. 1027-1036
|
article
|
| 67 |
Erratum to: Phenylephrine Pharmacokinetics and First-Pass Metabolism: What Is an Ideal Pharmacokinetic Surrogate?
|
Srinivas, Nuggehally R.
|
|
2015
|
|
12 |
p. 855
|
article
|
| 68 |
Evaluation of the Feasibility of a Web-Based Survey to Assess Patient-Reported Symptom Improvement and Treatment Satisfaction Among Patients with Psoriatic Arthritis Receiving Secukinumab
|
Magrey, Marina
|
|
2019
|
|
12 |
p. 1205-1212
|
article
|
| 69 |
Genetic Polymorphisms of SLCO1B1, CYP2E1 and UGT1A1 and Susceptibility to Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Chinese Population-Based Prospective Case–Control Study
|
Sun, Qin
|
|
|
|
12 |
p. 1125-1136
|
article
|
| 70 |
Genetic Polymorphisms of SLCO1B1, CYP2E1 and UGT1A1 and Susceptibility to Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Chinese Population-Based Prospective Case–Control Study
|
Sun, Qin
|
|
2017
|
|
12 |
p. 1125-1136
|
article
|
| 71 |
Glucagon-Like Peptide-1 Receptor Agonist and Risk of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials
|
Jiao, Xiaojuan
|
|
|
|
12 |
p. 915-926
|
article
|
| 72 |
Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment
|
Yeh, Nai-Lun
|
|
2019
|
|
12 |
p. 1195-1203
|
article
|
| 73 |
Hemoglobin Stability and Patient Satisfaction After Switch to C.E.R.A. Therapy: A Multicenter, Observational Study
|
Bozkurt, Fuat
|
|
2013
|
|
12 |
p. 939-940
|
article
|
| 74 |
Hormonal Contraception and Depression: Updated Evidence and Implications in Clinical Practice
|
Fruzzetti, Franca
|
|
|
|
12 |
p. 1097-1106
|
article
|
| 75 |
Impact of Loss of Work Productivity in Patients with Overactive Bladder Treated with Antimuscarinics in Spain: Study in Routine Clinical Practice Conditions
|
Sicras-Mainar, Antoni
|
|
2015
|
|
12 |
p. 795-805
|
article
|
| 76 |
Investigation of the Association Between Total and Free Plasma and Saliva Mycophenolic Acid Concentrations Following Administration of Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant Recipients
|
Brooks, Emily
|
|
2019
|
|
12 |
p. 1175-1184
|
article
|
| 77 |
In Vitro Drug Release After Crushing: Evaluation of Xtampza® ER and Other ER Opioid Formulations
|
Mayock, Stephen P.
|
|
|
|
12 |
p. 1117-1124
|
article
|
| 78 |
In Vitro Drug Release After Crushing: Evaluation of Xtampza® ER and Other ER Opioid Formulations
|
Mayock, Stephen P.
|
|
2017
|
|
12 |
p. 1117-1124
|
article
|
| 79 |
Is Alpelisib Plus Fulvestrant Cost-Effective for Treating PIK3CA-Mutation, HR+/HER2− Advanced Breast Cancer in the USA?
|
Wu, Wenhua
|
|
|
|
12 |
p. 939-948
|
article
|
| 80 |
Isolated and Spontaneous Correction of Proximal Interphalangeal Joint Contractures in Dupuytren’s Disease: An Exploratory Analysis of the Efficacy and Safety of Collagenase Clostridium histolyticum
|
Hayton, Michael J.
|
|
2013
|
|
12 |
p. 905-912
|
article
|
| 81 |
Is There Saturation in the Conversion of Baicalein to Baicalin After Oral Chewable Tablets: Retrospective Evaluation of the Human Pharmacokinetic Data?
|
Srinivas, Nuggehally R.
|
|
2016
|
|
12 |
p. 1075-1076
|
article
|
| 82 |
Lifetime Cost-Utility Analyses of Deferasirox in Beta-Thalassaemia Patients with Chronic Iron Overload
|
Karnon, Jonathan
|
|
2012
|
|
12 |
p. 805-815
|
article
|
| 83 |
Management of Cognitive Determinants in Senile Dementia of Alzheimer’s Type: Therapeutic Potential of a Novel Polyherbal Drug Product
|
Sadhu, Ananya
|
|
2014
|
|
12 |
p. 857-869
|
article
|
| 84 |
Medical Service Encounters and Payments Associated with Topical Adjunctive Therapy Use of Timolol for Glaucoma
|
Schmier, Jordana K.
|
|
2012
|
|
12 |
p. 835-842
|
article
|
| 85 |
Methodological Considerations for Comparison of Brand Versus Generic Versus Authorized Generic Adverse Event Reports in the US Food and Drug Administration Adverse Event Reporting System (FAERS)
|
Rahman, Md. Motiur
|
|
|
|
12 |
p. 1143-1152
|
article
|
| 86 |
Methodological Considerations for Comparison of Brand Versus Generic Versus Authorized Generic Adverse Event Reports in the US Food and Drug Administration Adverse Event Reporting System (FAERS)
|
Rahman, Md. Motiur
|
|
2017
|
|
12 |
p. 1143-1152
|
article
|
| 87 |
Methoxyflurane: A Review in Trauma Pain
|
Blair, Hannah A.
|
|
2016
|
|
12 |
p. 1067-1073
|
article
|
| 88 |
Monotherapy Versus Combination Therapy in the Treatment of Painful Diabetic Neuropathy: A Systematic Review and Meta-analysis
|
Medeiros Dantas, Julyana
|
|
|
|
12 |
p. 905-914
|
article
|
| 89 |
Multicenter, Open-Label Study of Long-Term Topiroxostat (FYX-051) Administration in Japanese Hyperuricemic Patients with or Without Gout
|
Hosoya, Tatsuo
|
|
2018
|
|
12 |
p. 1135-1143
|
article
|
| 90 |
Nivolumab-Induced Recurrence of Rheumatoid Arthritis in a Patient with Metastatic Gastric Adenocarcinoma
|
Nishikawa, Masataka
|
|
2019
|
|
12 |
p. 1251-1254
|
article
|
| 91 |
Non-Vitamin K Antagonist Oral Anticoagulant Treatment in Centenarians: A Series of Four Cases
|
Kuntzman, Yuval
|
|
2019
|
|
12 |
p. 1255-1258
|
article
|
| 92 |
Open-Label Study to Assess the Efficacy of Ipragliflozin for Reducing Insulin Dose in Patients with Type 2 Diabetes Mellitus Receiving Insulin Therapy
|
Ishihara, Hisamitsu
|
|
2019
|
|
12 |
p. 1213-1221
|
article
|
| 93 |
Oxycodone/Naloxone Prolonged Release: A Review in Severe Chronic Pain
|
Kim, Esther S.
|
|
|
|
12 |
p. 1191-1201
|
article
|
| 94 |
Oxycodone/Naloxone Prolonged Release: A Review in Severe Chronic Pain
|
Kim, Esther S.
|
|
2017
|
|
12 |
p. 1191-1201
|
article
|
| 95 |
Paliperidone Extended-Release: Safety and Tolerability from a Metabolic Profile Perspective
|
Rodríguez-Martínez, Alfonso
|
|
2013
|
|
12 |
p. 867-876
|
article
|
| 96 |
Pembrolizumab vs the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Cost-Effectiveness Analysis
|
Lang, Yitian
|
|
|
|
12 |
p. 1137-1146
|
article
|
| 97 |
Performance-Based Risk-Sharing Arrangements (PBRSA): Is it a Solution to Increase Bang for the Buck for Pharmaceutical Reimbursement Strategy for Our Nation and Around the World?
|
Kim, Andy Eunwoo
|
|
|
|
12 |
p. 1107-1113
|
article
|
| 98 |
Pharmacoepidemiological Study of Long-Acting β-agonist/Inhaled Corticosteroid Therapy and Asthma Mortality: Clinical Implications
|
Camargo, Carlos A.
|
|
2016
|
|
12 |
p. 993-999
|
article
|
| 99 |
Pharmacokinetic and Pharmacodynamic Profiles of a Fixed-Dose Combination of Olmesartan Medoxomil and Amlodipine in Healthy Chinese Males and Females
|
Chen, Xia
|
|
2012
|
|
12 |
p. 783-790
|
article
|
| 100 |
Pharmacokinetic Characterization of Tizanidine Nasal Spray, a Novel Intranasal Delivery Method for the Treatment of Skeletal Muscle Spasm
|
Vitale, Daniela Cristina
|
|
2013
|
|
12 |
p. 885-891
|
article
|
| 101 |
Pharmacokinetic Comparisons of Bepotastine Besilate and Bepotastine Salicylate in Healthy Subjects
|
Kim, Kyoung-Ah
|
|
2013
|
|
12 |
p. 913-919
|
article
|
| 102 |
Pharmacokinetic Properties of Intravenous Ibuprofen in Healthy Chinese Volunteers
|
Shen, Yali
|
|
2016
|
|
12 |
p. 1051-1058
|
article
|
| 103 |
Pharmacokinetics and Pharmacodynamics of Follicle-Stimulating Hormone in Healthy Women Receiving Single and Multiple Doses of Highly Purified Human Menotrophin and Urofollitrophin
|
Di Stefano, Andrea F. D.
|
|
2016
|
|
12 |
p. 1031-1044
|
article
|
| 104 |
Pharmacokinetics and Pharmacodynamics of JNJ-55920839, an Antibody Targeting Interferon α/ω, in Healthy Subjects and Subjects with Mild-to-Moderate Systemic Lupus Erythematosus
|
Yao, Zhenling
|
|
|
|
12 |
p. 1127-1136
|
article
|
| 105 |
Pharmacokinetics and Preliminary Pharmacodynamics of Single- and Multiple-dose Lyophilized Recombinant Glucagon-like Peptide-1 Receptor Agonist (rE-4) in Chinese Patients with Type 2 Diabetes Mellitus
|
Wang, Yitong
|
|
|
|
12 |
p. 1107-1115
|
article
|
| 106 |
Pharmacokinetics and Preliminary Pharmacodynamics of Single- and Multiple-dose Lyophilized Recombinant Glucagon-like Peptide-1 Receptor Agonist (rE-4) in Chinese Patients with Type 2 Diabetes Mellitus
|
Wang, Yitong
|
|
2017
|
|
12 |
p. 1107-1115
|
article
|
| 107 |
Pharmacokinetics and Safety of Ezetimibe/Simvastatin Combination Tablet
|
Chu, Nan-Nan
|
|
2012
|
|
12 |
p. 791-798
|
article
|
| 108 |
Pharmacokinetics of a Fixed-Dose Combination of Mitiglinide and Metformin versus Concurrent Administration of Individual Formulations in Healthy Subjects
|
Jung, Jin Ah
|
|
2012
|
|
12 |
p. 799-804
|
article
|
| 109 |
Pharmacokinetics of Glepaglutide, A Long-Acting Glucagon-Like Peptide-2 Analogue: A Study in Healthy Subjects
|
Agersnap, Mikkel Askjær
|
|
|
|
12 |
p. 1093-1100
|
article
|
| 110 |
Pharmacokinetics of Morphine Sulfate Orodispersible Tablets and Bioequivalence with Immediate-Release Oral Morphine Sulfate Formulations in Healthy Adult Subjects Under Fasting Conditions: Single-Dose Comparative Bioavailability Studies
|
Atrux-Tallau, Nicolas
|
|
|
|
12 |
p. 1101-1112
|
article
|
| 111 |
Pharmacokinetics of Repeated Melatonin Drug Administrations Prior to and After Surgery
|
Harpsøe, Nathja Groth
|
|
2016
|
|
12 |
p. 1045-1050
|
article
|
| 112 |
Pharmacokinetics, Pharmacodynamics and Population Pharmacokinetic/Pharmacodynamic Modelling of Bilastine, a Second-Generation Antihistamine, in Healthy Japanese Subjects
|
Togawa, Michinori
|
|
2016
|
|
12 |
p. 1011-1021
|
article
|
| 113 |
Pharmacokinetics, Safety, and Tolerability of a Single 500-mg or 1000-mg Intravenous Dose of Dalbavancin in Healthy Japanese Subjects
|
Scoble, Patrick J.
|
|
2015
|
|
12 |
p. 785-793
|
article
|
| 114 |
Phenylephrine Pharmacokinetics and First-Pass Metabolism: What Is an Ideal Pharmacokinetic Surrogate?
|
Srinivas, Nuggehally R.
|
|
2015
|
|
12 |
p. 851-853
|
article
|
| 115 |
Phenylephrine Pharmacokinetics and First-Pass Metabolism: What Is an Ideal Pharmacokinetic Surrogate?
|
Srinivas, Nuggehally R.
|
|
|
|
12 |
p. 851-853
|
article
|
| 116 |
Prevalence of Desloratadine Slow-metabolizer Phenotype and Food-dependent Pharmacokinetics of Desloratadine in Healthy Chinese Volunteers
|
Wang, Ting
|
|
2015
|
|
12 |
p. 807-813
|
article
|
| 117 |
Randomized Comparison Study of Novel Recombinant Human Antithrombin Gamma and Plasma-Derived Antithrombin in Healthy Volunteers
|
Furuie, Hidetoshi
|
|
2019
|
|
12 |
p. 1185-1194
|
article
|
| 118 |
Rationale for the Use of a Fixed-Dose Combination in the Management of Hypertension
|
Borghi, Claudio
|
|
2010
|
|
12 |
p. 843-854
|
article
|
| 119 |
Reduction of Immune Activation and Partial Recovery of Staphylococcal Enterotoxin B-Induced Cytokine Production After Switching to an Integrase Strand Transfer Inhibitor-Containing Regimen: Results from an Observational Cohort Study
|
Merlini, Esther
|
|
2019
|
|
12 |
p. 1239-1249
|
article
|
| 120 |
Replacement Effects and Budget Impacts of Insurance Coverage for Sodium-Glucose Co-Transporter-2 Inhibitors on Oral Antidiabetic Drug Utilization
|
Chen, Hsiang-Yin
|
|
2018
|
|
12 |
p. 1125-1133
|
article
|
| 121 |
Response to “Comment on: Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database”
|
Kazerooni, Rashid
|
|
2018
|
|
12 |
p. 1199-1200
|
article
|
| 122 |
RETRACTED ARTICLE: Reduction of Propofol-Induced Pain through Pretreatment with Lidocaine and/or Flurbiprofen
|
Fujii, Yoshitaka
|
|
2004
|
|
12 |
p. 749-753
|
article
|
| 123 |
Risk Factors for and Incidence of Seizures in Metastatic Castration-Resistant Prostate Cancer: A Real-World Retrospective Cohort Study
|
Dharmani, Charles
|
|
|
|
12 |
p. 1183-1190
|
article
|
| 124 |
Risk Factors for and Incidence of Seizures in Metastatic Castration-Resistant Prostate Cancer: A Real-World Retrospective Cohort Study
|
Dharmani, Charles
|
|
2017
|
|
12 |
p. 1183-1190
|
article
|
| 125 |
Role of Ramelteon in Reduction of As-Needed Antipsychotics in Elderly Patients with Delirium in a General Hospital Setting
|
Pinkhasov, Aaron
|
|
|
|
12 |
p. 1137-1141
|
article
|
| 126 |
Role of Ramelteon in Reduction of As-Needed Antipsychotics in Elderly Patients with Delirium in a General Hospital Setting
|
Pinkhasov, Aaron
|
|
2017
|
|
12 |
p. 1137-1141
|
article
|
| 127 |
Safety and Effectiveness of Letermovir in Allogenic Hematopoietic Stem Cell Transplantation Recipients: Interim Report of Post-marketing Surveillance in Japan
|
Hiraishi, Itaru
|
|
|
|
12 |
p. 1075-1086
|
article
|
| 128 |
Safety Concerns with Nusinersen, Risdiplam, and Onasemnogene Abeparvovec in Spinal Muscular Atrophy: A Real-World Pharmacovigilance Study
|
Zhuang, Wei
|
|
|
|
12 |
p. 949-962
|
article
|
| 129 |
Safety, Pharmacokinetics, and Pharmacodynamics of Globalagliatin, a Glucokinase Activator, in Chinese Patients with Type 2 Diabetes Mellitus: A Randomized, Phase Ib, 28-day Ascending Dose Study
|
Zheng, Shuai
|
|
|
|
12 |
p. 1155-1166
|
article
|
| 130 |
Safety, Tolerability and Pharmacokinetics of Sugammadex Using Single High Doses (Up to 96 mg/kg) in Healthy Adult Subjects
|
Peeters, Pierre A. M.
|
|
2010
|
|
12 |
p. 867-874
|
article
|
| 131 |
Safety, Tolerability, and Pharmacokinetics of the Novel Anti-influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study Findings
|
Koshimichi, Hiroki
|
|
2018
|
|
12 |
p. 1189-1196
|
article
|
| 132 |
SGLT2 Inhibitors Improve Cardiac Failure by Reducing Whole-Body Oxygen Demand: A Hypothesis
|
Onoue, Takeshi
|
|
|
|
12 |
p. 1025-1030
|
article
|
| 133 |
Short-Term Impact of Low-Dose Atorvastatin on Serum Proprotein Convertase Subtilisin/Kexin Type 9
|
Guo, Yuan-Lin
|
|
2013
|
|
12 |
p. 877-883
|
article
|
| 134 |
Signal Detection Between Fluoroquinolone Use and the Risk of Rhegmatogenous Retinal Detachment: Sequence Symmetry Analysis Using Nationwide South Korean Healthcare Database Between 2004 and 2015
|
Baek, Yeon-Hee
|
|
2018
|
|
12 |
p. 1179-1188
|
article
|
| 135 |
Single-Dose, Open-Label Study of the Differences in Pharmacokinetics of Colchicine in Subjects with Renal Impairment, Including End-Stage Renal Disease
|
Wason, Suman
|
|
2014
|
|
12 |
p. 845-855
|
article
|
| 136 |
Subcutaneous Infliximab, CT-P13 SC: A Profile of Its Use in the EU
|
Shirley, Matt
|
|
|
|
12 |
p. 1099-1107
|
article
|
| 137 |
Subjective Effects and Safety of Whole and Tampered Morphine Sulfate and Naltrexone Hydrochloride (ALO-01) Extended-Release Capsules versus Morphine Solution and Placebo in Experienced Non-Dependent Opioid Users
|
Stauffer, Joseph
|
|
2009
|
|
12 |
p. 777-790
|
article
|
| 138 |
Sublingual Fentanyl Tablets for Relief of Breakthrough Pain in Cancer Patients and Association with Quality-of-Life Outcomes
|
Guitart, Jordi
|
|
2015
|
|
12 |
p. 815-822
|
article
|
| 139 |
Targeted Oral Therapies in the Treatment of Pulmonary Arterial Hypertension
|
Safdar, Zeenat
|
|
2010
|
|
12 |
p. 811-826
|
article
|
| 140 |
Tauro-Urso-Deoxycholic Acid Trials in Amyotrophic Lateral Sclerosis: What is Achieved and What to Expect
|
Lo Giudice, Maria
|
|
|
|
12 |
p. 893-903
|
article
|
| 141 |
The CITIRIVAD Study: CITIcoline plus RIVAstigmine in Elderly Patients Affected with Dementia Study
|
Castagna, Alberto
|
|
2016
|
|
12 |
p. 1059-1065
|
article
|
| 142 |
The Effect of Nitazoxanide on the Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
|
Abuelazm, Mohamed
|
|
|
|
12 |
p. 1031-1047
|
article
|
| 143 |
The Effects of Novel Antidiabetic Drugs on Albuminuria in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials
|
Luo, Ya
|
|
2018
|
|
12 |
p. 1089-1108
|
article
|
| 144 |
The Impact of Rosuvastatin on the Density Score of Coronary Artery Calcification in Coronary Artery Disease Patients with Type 2 Diabetes Mellitus: Rationale and Design of RosCal Study
|
Zhang, Wenbin
|
|
2016
|
|
12 |
p. 1023-1029
|
article
|
| 145 |
The Intraoperative Median Effective Dose of Oxytocin for Preventing Uterine Atony in Parturients with a Prior History of Caesarean Delivery
|
Wei, Chang Na
|
|
|
|
12 |
p. 1047-1053
|
article
|
| 146 |
Treatment of Major Depressive Disorder in Japanese Patients with Cancer: A Matched Cohort Study Using Employer-Based Health Insurance Claims Data
|
Akechi, Tatsuo
|
|
|
|
12 |
p. 1115-1125
|
article
|
Journal description